OnCore Login

Return to Trial Database

HCRN-BRE20-442

Phase II Study of The Combination of Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial HCRN-BRE20-442 being conducted in.
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278